Related Experiment Video

Updated: Aug 19, 2026

Analysis of Oxidative Stress in Zebrafish Embryos
11:05

Analysis of Oxidative Stress in Zebrafish Embryos

Published on: July 7, 2014

Oxidative stress, ER stress, and the JNK pathway in type 2 diabetes

Hideaki Kaneto1, Taka-Aki Matsuoka, Yoshihisa Nakatani

  • 1Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. kaneto@medone.med.osaka-u.ac.jp

Journal of Molecular Medicine (Berlin, Germany)
|March 11, 2005
PubMed

Insights

The JNK pathway is activated in type 2 diabetes, impairing insulin function and worsening glucose control. Inhibiting this pathway in diabetic mice improved insulin resistance and glucose tolerance, suggesting it

Area of Science:

  • Biochemistry and Molecular Biology
  • Endocrinology
  • Metabolic Diseases

Background:

  • Type 2 diabetes is characterized by pancreatic beta-cell dysfunction and insulin resistance.
  • Diabetic conditions induce oxidative stress and endoplasmic reticulum (ER) stress, activating the c-Jun N-terminal kinase (JNK) pathway.
  • JNK pathway activation is implicated in suppressing insulin biosynthesis and interfering with insulin action.

Purpose of the Study:

  • To investigate the role of the JNK pathway in the pathogenesis of type 2 diabetes.
  • To evaluate the therapeutic potential of targeting the JNK pathway for diabetes treatment.

Main Methods:

  • Utilized a mouse model of diabetes.
  • Assessed the effects of suppressing the JNK pathway on insulin resistance and glucose tolerance.

Main Results:

  • Suppression of the JNK pathway in diabetic mice led to significant improvements in insulin resistance.
  • Amelioration of glucose tolerance was observed following JNK pathway inhibition in diabetic mice.

Conclusions:

  • The JNK pathway plays a critical role in the development of type 2 diabetes.
  • Targeting the JNK pathway represents a promising therapeutic strategy for managing type 2 diabetes.

More Related Videos

A Murine Pancreatic Islet Cell-based Screening for Diabetogenic Environmental Chemicals07:39

A Murine Pancreatic Islet Cell-based Screening for Diabetogenic Environmental Chemicals

Published on: June 25, 2018

A Microfluidic System for Modeling Endothelial Dysfunction under Combined Physiological Pulsatile Shear Stress and Oscillatory Hyperglycemia14:10

A Microfluidic System for Modeling Endothelial Dysfunction under Combined Physiological Pulsatile Shear Stress and Oscillatory Hyperglycemia

Published on: May 12, 2026

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...